104 related articles for article (PubMed ID: 16515500)
1. Alpha2-antiplasmin on cardiovascular diseases.
Matsuno H
Curr Pharm Des; 2006; 12(7):841-7. PubMed ID: 16515500
[TBL] [Abstract][Full Text] [Related]
2. Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
Matsuno H; Kozawa O; Yoshimi N; Akamatsu S; Hara A; Mori H; Okada K; Ueshima S; Matsuo O; Uematsu T
Blood; 2002 Oct; 100(7):2487-93. PubMed ID: 12239160
[TBL] [Abstract][Full Text] [Related]
3. Plasmin generation plays different roles in the formation and removal of arterial and venous thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
Thromb Haemost; 2002 Jan; 87(1):98-104. PubMed ID: 11848464
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of fibrinolytic components play different roles in the formation and removal of arterial thrombus in mice.
Matsuno H; Kozawa O; Okada K; Ueshima S; Matsuo O; Uematsu T
J Cardiovasc Pharmacol; 2002 Feb; 39(2):278-86. PubMed ID: 11791014
[TBL] [Abstract][Full Text] [Related]
5. Alpha2-antiplasmin plays a significant role in acute pulmonary embolism.
Matsuno H; Okada K; Ueshima S; Matsuo O; Kozawa O
J Thromb Haemost; 2003 Aug; 1(8):1734-9. PubMed ID: 12911586
[TBL] [Abstract][Full Text] [Related]
6. Lack of alpha 2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice.
Matsuno H; Ishisaki A; Nakajima K; Okada K; Ueshima S; Matsuo O; Kozawa O
Blood; 2003 Nov; 102(10):3621-8. PubMed ID: 12893771
[TBL] [Abstract][Full Text] [Related]
7. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
Dewerchin M; Collen D; Lijnen HR
Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
[TBL] [Abstract][Full Text] [Related]
8. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
9. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
[TBL] [Abstract][Full Text] [Related]
10. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T
Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182
[TBL] [Abstract][Full Text] [Related]
11. Lack of alpha 2-antiplasmin enhances ADP induced platelet micro-aggregation through the presence of excess active plasmin in mice.
Takei M; Matsuno H; Okada K; Ueshima S; Matsuo O; Kozawa O
J Thromb Thrombolysis; 2002 Dec; 14(3):205-11. PubMed ID: 12913400
[TBL] [Abstract][Full Text] [Related]
12. Gene targeting in hemostasis. Alpha2-antiplasmin.
Lijnen HR
Front Biosci; 2001 Feb; 6():D239-47. PubMed ID: 11171550
[TBL] [Abstract][Full Text] [Related]
13. The kidney is a major site of alpha(2)-antiplasmin production.
Menoud PA; Sappino N; Boudal-Khoshbeen M; Vassalli JD; Sappino AP
J Clin Invest; 1996 Jun; 97(11):2478-84. PubMed ID: 8647939
[TBL] [Abstract][Full Text] [Related]
14. Lack of alpha2-antiplasmin improves cutaneous wound healing via over-released vascular endothelial growth factor-induced angiogenesis in wound lesions.
Kanno Y; Hirade K; Ishisaki A; Nakajima K; Suga H; Into T; Matsushita K; Okada K; Matsuo O; Matsuno H
J Thromb Haemost; 2006 Jul; 4(7):1602-10. PubMed ID: 16839360
[TBL] [Abstract][Full Text] [Related]
15. Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasmin.
Robbie LA; Bennett B; Keyt BA; Booth NA
Br J Haematol; 2000 Nov; 111(2):517-23. PubMed ID: 11122093
[TBL] [Abstract][Full Text] [Related]
16. Lack of both α2-antiplasmin and plasminogen activator inhibitor type-1 induces high IgE production.
Okada K; Ueshima S; Kawao N; Yano M; Tamura Y; Tanaka M; Sakamoto A; Hatano M; Arima M; Miyata S; Nagai N; Tokuhisa T; Matsuo O
Life Sci; 2013 Jul; 93(2-3):89-95. PubMed ID: 23770230
[TBL] [Abstract][Full Text] [Related]
17. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.
Carmeliet P; Moons L; Dewerchin M; Mackman N; Luther T; Breier G; Ploplis V; Müller M; Nagy A; Plow E; Gerard R; Edgington T; Risau W; Collen D
Ann N Y Acad Sci; 1997 Apr; 811():191-206. PubMed ID: 9186598
[TBL] [Abstract][Full Text] [Related]
18. Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleeding.
Lijnen HR; Okada K; Matsuo O; Collen D; Dewerchin M
Blood; 1999 Apr; 93(7):2274-81. PubMed ID: 10090937
[TBL] [Abstract][Full Text] [Related]
19. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
[TBL] [Abstract][Full Text] [Related]
20. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]